Description
Seeking men and women with non-alcoholic steatohepatitis (NASH) cirrhosis for a study of an investigational drug to reduce the amount of fat and inflammation in the liver.
Overview
Participants in this study will be randomly assigned to take either the investigational drug or a placebo (looks like the investigational drug but contains no medicine). There will be up to 19 study visits over a period of 3 years and 3 months.
What we're hoping for
Additional Information
ClinicalTrials.gov Identifier: NCT05500222